1. Home
  2. TWAV vs CLGN Comparison

TWAV vs CLGN Comparison

Compare TWAV & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TaoWeave Inc. Common Stock

TWAV

TaoWeave Inc. Common Stock

N/A

Current Price

$1.36

Market Cap

4.9M

Sector

Technology

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

N/A

Current Price

$0.33

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWAV
CLGN
Founded
N/A
2004
Country
United States
Israel
Employees
130
N/A
Industry
Computer Software: Programming Data Processing
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.2M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
TWAV
CLGN
Price
$1.36
$0.33
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
41.7K
59.9K
Earning Date
05-13-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
90.77
N/A
EPS
0.43
N/A
Revenue
$2,437,000.00
N/A
Revenue This Year
N/A
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
$3.21
N/A
Revenue Growth
2.48
N/A
52 Week Low
$0.58
$0.27
52 Week High
$2.58
$3.18

Technical Indicators

Market Signals
Indicator
TWAV
CLGN
Relative Strength Index (RSI) 58.10 44.20
Support Level $1.11 $0.29
Resistance Level $1.45 $0.44
Average True Range (ATR) 0.10 0.04
MACD 0.01 0.00
Stochastic Oscillator 89.36 31.42

Price Performance

Historical Comparison
TWAV
CLGN

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: